Alkeran


Also found in: Thesaurus, Medical, Wikipedia.
Related to Alkeran: multiple myeloma
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Alkeran - antineoplastic drug (trade name Alkeran) used to treat multiple myeloma and some other malignanciesAlkeran - antineoplastic drug (trade name Alkeran) used to treat multiple myeloma and some other malignancies
antineoplastic, antineoplastic drug, cancer drug - any of several drugs that control or kill neoplastic cells; used in chemotherapy to kill cancer cells; all have unpleasant side effects that may include nausea and vomiting and hair loss and suppression of bone marrow function
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
1] Similarly, Aspen, which is the dominant firm in the provision of Leukeran (chlorambucil), Alkeran (melphalan) and Myleran (busulfan) in SA, has seemingly taken advantage of their monopoly in the market and are under investigation for excessive pricing of these medicines.
Trade names Generic names Dosage form Strengths Mvleran Busulphan Tablet 2mg/Tablet Leukeran Chlorambucil Tablet 2mg/Tablet Endoxan Cyclophosphamide White Powder 200mg/Vial Anhvdrous Injection Endoxan Cyclophosphamide White Powder 500mg/Vial Anhydrous Injection Endoxan Cyclophosphamide White Powder 1gm/Vial Anhydrous Injection Endoxan Cyclophosphamide Tablet 50mg/Tablet Anhydrous Holoxan Ifosfamide Injection 1gm/Vial Holoxan Ifosfamide Injection 2gm/Vial Alkeran Melphalan Tablet 2mg/Tablet Uromitexan Mesna Injection 100mg/ml.
Melphalan Hydrochloride Synerx Pharma LLC Alkeran for
14) The pharmacist mistook chlorambucil, the generic drug prescribed by her physician, for alkeran, the generic name for Melphalen--a substantially more powerful prescription drug that requires more careful monitoring.
Where the method of administration is critical--for example, avoiding or treating extravasation of Alkeran.
The Phase II study successfully met all endpoints, with the new PG-free Melphalan showing to be bioequivalent to Alkeran per guidance requirements, while also demonstrating a marginally higher systemic drug exposure (112%).